ResMed, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
No of Months
12
12
12
12
12
12
Profit Before Tax
1,264.00
1,101.00
960.00
883.00
733.00
518.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
44.00
-462.00
-708.00
1.00
-97.00
-177.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,401.00
693.00
351.00
736.00
802.00
459.00
Cash Flow from Investing Activities
-269.00
-1,159.00
-229.00
-158.00
-179.00
-1,075.00
Cash Flow from Financing Activities
-1,119.00
422.00
-128.00
-764.00
-317.00
580.00
Net Cash Inflow / Outflow
10.00
-45.00
-21.00
-167.00
316.00
-41.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
-2.00
-14.00
18.00
10.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ResMed, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
1264.798
608.959
656.00
107.70%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
44.784
-72.433
116.00
161.83%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1401.26
738.231
663.00
89.81%
Cash Flow from Investing Activities
-269.784
-254.912
-15.00
-5.83%
Cash Flow from Financing Activities
-1119.287
-355.722
-764.00
-214.65%
Net Cash Inflow / Outflow
10.47
106.444
-96.00
-90.16%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.719
-21.153
20.00
91.87%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'24
YoY Growth in year ended Jun 2024 is 102.11% vs 97.44% in Jun 2023
Jun'24
Jun'23
Change(%)
Cash Flow from Operating Activities
1,401.26
693.30
102.11%






